
CDCã¬ããŒããCOVIDã¯ã¯ãã³å±é以æ¥ã50äžäººã®ã¢ã¡ãªã«ã®åäŸãšè¥è ãæ»äº¡ã確èªãè±åœæ¿åºã®ã¬ããŒãããCOVIDã¯ã¯ãã³æ¥çš®ãåå ã§ããå¯èœæ§ã確èª
å èšäºã¯ãã¡ã/Original article here
ç±³åœçŸç 察çã»ã³ã¿ãŒïŒCDCïŒãã²ã£ãããšçºè¡šããå ¬åŒã®æ°åã§ã¯ãç±³åœã§é£åå»è¬åå±ãã³ãã19ã¯ã¯ãã³ã«åããŠç·æ¥äœ¿çšèš±å¯ãäžããŠä»¥æ¥ã50äžäººè¿ãã®åäŸãšè¥è ãæ»äº¡ããŠããããšã確èªãããŠããŸãã
ããã¯æ²ããããšã«ã2015幎ãã2019幎ã®å¹³åãšæ¯èŒããŠãçŽ118,000人ã®éå°ãªæ»äº¡ããããããŸããã
ãŸãããã®æ°åã¯ãCovid-19ã®å€§æµè¡ãçããã2020幎ã®åææãšæ¯èŒããŠããããŸã§ã®ãšãã2022幎ã®åäŸãšè¥å¹Žæäººã®è¶ éæ»äº¡ã7,680人å€ãããšãæããã«ããŠããŸãã
ãããã2021幎ã¯0æ³ãã44æ³ãŸã§ã®æ»è æ°ãå§åçã«å€ããåèšã§291,461人ã®è¶ éæ»äº¡ãçºçãã2020幎ã«çºçããããã6äžäººè¿ãå€ããªã£ãŠããã®ã§ãããããŠãCDCã®å ¬åŒçºè¡šã«ããã°ãããã¯äž»ã«31é±ç®ãããããåäŸãè¥å¹Žå±€ã®æ»äº¡ãè¬ã®æ¥å¢ããŠããããšã«èµ·å ããŠããã
æ®å¿µãªãããè±åœæ¿åºãçºè¡šããããŒã¿ã«ãããšã2020幎åŸåãã50äžäººã®ã¢ã¡ãªã«ã®åäŸãšè¥è ãæ»äº¡ããèŠå ãšãªã£ããã®ãè¬ã®ãæ¥æ¿ãªäžæã¯ãã³ãã19泚å°ãåå ã§ããå¯èœæ§ãé«ãã®ã ããã§ãã
ä»ã®åœã ãšæ¯ã¹ãŠãç±³åœæ¿åºã¯ã³ããã19泚å°ã®çµæãåæããããã®é©åãªææ°ããŒã¿ãå ¬è¡šããããšãèŠæã§ãããããããçµæžååéçºæ©æ§(OEC)ãšããæ©é¢ã®ãããã§ããããããããçºèŠããããšãã§ããã
OECã¯ãçµæžçºå±ãšäžç貿æãä¿é²ããããã«1961幎ã«èšç«ããã38ã«åœãå çããæ¿åºéæ©é¢ã§ããããããŠãªãããéå°æ»äº¡ã«é¢ããè±å¯ãªããŒã¿ãä¿æããŠããããã®ããŒã¿ã¯ããã¡ãã§ã芧ããã ããŸãã
以äžã®å³ã¯ãOECã®ããŒã¿ããŒã¹ã«ããæ°åãå©çšããŠäœæãããã®ã§ãããç±³åœçŸç 管çã»ã³ã¿ãŒïŒCDCïŒããOECã«æäŸãããæ°åã§ãããããŠã2020幎ãš2021幎ã®ã¢ã¡ãªã«å šåã®0ïœ44æ³ã®åäŸãšè¥å¹Žæäººã®è¶ éæ»äº¡ãé±ããšã«ç€ºãããã®ã§ãã

å ¬åŒã®æ°åã«ãããšã2020幎åé ã«Covid-19ã®ãã³ãããã¯ãšããããã®ãç±³åœã§çºçããéãåäŸãè¥å¹Žå±€ã®éå°æ»äº¡ããããã«å¢å ããããšãæããã«ãªã£ãã
ããããã³ããã-19泚å°ã®å°å ¥ã«ããã2021幎ã«ã¯ãã®å¹Žéœ¢å±€ã®æ»äº¡æ°ãå€§å¹ ã«æžå°ããŠãããšäºæ³ãããã ããããããããã®ä»£ããã«éã®ããšãèµ·ãã£ãã
å°å ãšè¥å¹Žæäººã®éå°æ»äº¡ã¯ã29é±ãš30é±ãé€ããŠã2021幎ã«ã¯2020幎ããããã¹ãŠã®é±ã§ææã«é«ããªã£ãã®ã§ãããããã31é±ç®ã«ã¯ãåäŸãšè¥å¹Žæäººã®éå°æ»äº¡ãå€§å¹ ã«å¢å ãããšããåçãªããšãèµ·ãããŸããã
ãããŠãCDCãæäŸããå ¬åŒã®æ°åã¯ãæ®å¿µãªãããã®åŸåã2022幎ãç¶ããŠããããšã瀺ããŠããŸãã

CDCãçºè¡šããææ°ã®ããŒã¿ã¯ã10æ9æ¥ã«çµãã第40é±ãŸã§ã察象ãšããŠãããããæ°é±éã®ããŒã¿ã¯å€æŽãããå¯èœæ§ãããããšã«æ³šæãå¿ èŠã§ããããããäžèšãããããããã«ã2022幎ãåäŸãè¥å¹Žå±€ã®éå°æ»äº¡ãé¡èãªå¹Žãšãªã£ãŠããŸãã
æ¯èŒã®ããã«ããããŸã§ã®2022å¹Žã®æ°åãã2020幎ã2021幎ã®ãŠã£ãŒ40ãŸã§ã®æ°åãšæ¯èŒããŠã¿ããšã次ã®ããã«ãªããŸãã

CDCã¯ã2022幎ã®å°å ããã³è¥å¹Žæäººã®éå°æ»äº¡ããã³ããã-19ãã³ãããã¯çæã®æçæã§ãã2020幎ã®åææããã7,680ä»¶å€ãããšã確èªããŸããã
ãããã2021幎ã¯å§åçã«ææªã§ãã³ããã19泚å°ã®å±éåŸ40é±ç®ãŸã§ã«ãã³ããã19ãã³ãããã¯ãšãããæçæã®2020幎ã«çºçãããã®ããã27,227人å€ãè¶ éæ»äº¡ãçºçããŠããŸãã
以äžã®ã°ã©ãã¯ãã³ããã19ã¯ã¯ãã³å±éåãšã2020幎12æ14æ¥ã®ã³ããã19ã¯ã¯ãã³å±éåŸã®ãç±³åœå šåã®å°å ã»è¥å¹Žæäººã®å šæ»äº¡ãšè¶ éæ»äº¡ã«é¢ããCDCã®å ¬åŒæ°å€ã瀺ããŠããŸãã

äžèšã®æ°åã¯ã2020幎ã¯ã³ãããã³ãããã¯ã®æçæãšãããããã«11é±éåã®æ»äº¡ãå«ãŸããŠããã«ããããããã2022幎ã®ãããŸã§ã®ãšããã0ïœ44æ³ã®éå°æ»äº¡ã40é±ãŸã§ã«çºçãããã®ããã1352人å°ãªãã ãã§ããããšãæããã«ããŠããŸãã
ããããäžèšã®ã°ã©ãã§æããã«ãªã£ãæãæ°ã«ãªãæ°åã¯ãã³ããã-19泚å°ã®å±é以æ¥ãåäŸãšè¥å¹Žæäººã®æ»äº¡æ°ããã³è¶ éæ»äº¡æ°ã®å šäœçãªæ°ã§ããã
2020幎ã®ç¬¬51é±ä»¥éã0æ³ãã44æ³ãŸã§ã®çŽ50äžäººãæ²ããããšã«æ»äº¡ãããã®çµæã2015幎ãã2019幎ã®5幎平åã«å¯ŸããŠ117,719人ãšããé©ç°çãªè¶ éæ»äº¡ãçºçããŠããã®ã§ãã
2020幎æç¹ã®ã¢ã¡ãªã«ã®å¹³å寿åœã¯77.28æ³ã§ãããCovid-19ã¯æ»ã«è³ãç æ°ã§ãããšããå ¬åŒã®èª¬æãä¿¡ãããªãã°ã2020幎ã«231,987人ã®44æ³ãŸã§ã®åäŸãšè¥è ãæ»äº¡ãã40,365人ãéå°ã«æ»äº¡ããããšã¯ããããããã®ç æ°ã®äžå¹žãªçµæã§ãããšçŽåŸã§ããã ããã
ããããã³ããã19泚å°ã¯å®å šã§å¹æçã§ãããšããå ¬åŒã®èª¬æãä¿¡ããã®ã§ããã°ã2021幎ãš2022幎ã®äž¡æ¹ã§åäŸãšè¥è ã®æ»äº¡ãããã«å¢å ããããšãã©ã説æã§ããã§ããããã
ãªããªããäœçŸäžäººãã®ã¢ã¡ãªã«äººã匷å¶çã«æ³šå°ãæããããäœçŸäžäººãã®èŠªã匷å¶çã«èªåã®åã©ãã«ãåãæ³šå°ãæãããããšãåãã£ãŠããããã§ãã
ãã®çãã¯ãå ¬åŒçºè¡šãçã£èµ€ãªåã§ããããšã«ãããŸããã³ãã19ã¯ã¯ãã³ã¯ãã®ã©ã¡ãã§ããªãã
CDCãæäŸããããŒã¿ã¯ãä¿¡ããããªãã»ã©èŠã€ãã«ãããã®ã§ãã¢ã¡ãªã«ã®è¥è ã®éã§å€ãã®æ»è ãåºãŠããããšã瀺ãæããããäžããŠãããã«éããªããããããè±åœæ¿åºãçºè¡šããæŽãªãããŒã¿ããããè£ä»ããŠããã
ãããè£ä»ãã蚌æ ã®ã²ãšã€ãã2022幎7æ6æ¥ã«è±åœæ¿åºæ©é¢ã§ããåœå®¶çµ±èšå±ãçºè¡šããå ±åæžã§ããã
å ±åæžã®ã¿ã€ãã«ã¯ãDeaths by Vaccination Status, England, 1 January 2021 to 31 May 2022ãã§ãONSã®ãµã€ãã§ã¯ãã¡ãããã¢ã¯ã»ã¹ã§ããããŠã³ããŒããå¯èœã§ãã

å ±åæžã®è¡š2ã¯ã2022幎5æãŸã§ã®ã€ã³ã°ã©ã³ãã«ããã10äžäººå¹Žåœããã®æ»äº¡çã«ã€ããŠã幎霢局å¥ã®ã¯ã¯ãã³æ¥çš®ç¶æ³ã«ããå¹Žéœ¢æšæºåæ»äº¡çã®æå¥æšç§»ã瀺ãããã®ã§ãã
ONSããæäŸããã2022幎1æãã5æãŸã§ã®æ°åãããšã«ãCovid-19ã®éå£äºé²æ¥çš®ãã£ã³ããŒã³ã®æãããçµæãæããã«ãã以äžã®ã°ã©ããäœæããŸããã
ãã®ã°ã©ãã¯ã2022幎1æãã5æãŸã§ã®ã€ã³ã°ã©ã³ãã«ããã18æ³ãã39æ³ã®éã³ãã19ã®æ»äº¡ã«ã€ããŠãã¯ã¯ãã³æ¥çš®ã®æç¡ã«ããå¹Žéœ¢æšæºåæ»äº¡çã®ææ¬¡æšç§»ã瀺ããŠãã - ã

2022幎ã«å ¥ã£ãŠãããã¹ãŠã®åæã§ãäžéšæ¥çš®ãšäºéæ¥çš®ã®18æ³ãã39æ³ã¯ãæªæ¥çš®ã®18æ³ãã39æ³ãããæ»äº¡çãé«ããªã£ãŠããŸãããããã3åæ¥çš®ã®18æ³ãã39æ³ã¯ã2021幎12æã«è±åœã§çºçããå€§èŠæš¡ãªBoosterãã£ã³ããŒã³ã®åŸãæããšã«æ»äº¡çãæªåããŠããã
1æã§ã¯ãããªãã«ã¯ã¯ãã³æ¥çš®ã®18æ³ãã39æ³ã®æ»äº¡çã¯ãã¯ã¯ãã³æªæ¥çš®ã®18æ³ãã39æ³ã®æ»äº¡çãããããã«äœãã10äžäººããã29.8人ãããªãã«ã¯ã¯ãã³æ¥çš®è ã®æ»äº¡çã¯28.1人ã§ããã
ãããã2æä»¥éã«ãªããšäžå€ããã2æã«ã¯ã18æ³ãã39æ³ã®3皮混åã¯ã¯ãã³æ¥çš®è ãã¯ã¯ãã³æªæ¥çš®ã®18æ³ãã39æ³ããã27ïŒ æ»äº¡çãé«ããªããæ»äº¡çã¯3皮混åã¯ã¯ãã³æ¥çš®è ã10äžäººããã26.7äººãæªæ¥çš®è ã10äžäººããã21人ãšãªã£ãã
ããããæ®å¿µãªããã2022幎5æãŸã§ã«3皮混åã¯ã¯ãã³æ¥çš®è ã®ç¶æ³ã¯ããã«æªåãããããŒã¿ã«ãããšã5æã«3皮混åã¯ã¯ãã³ãæ¥çš®ãã18æ³ãã39æ³ã¯ãæªæ¥çš®ã®18æ³ãã39æ³ãããæ»äº¡ãã確çã52ïŒ é«ããæ»äº¡çã¯10äžäººããã3皮混åã¯ã¯ãã³æ¥çš®è ã§21.4äººãæªæ¥çš®è ã§14.1人ã§ãã£ãã
ãããããããŸã§ã§ææªã®æ°å€ã¯ãäžéšæ¥çš®è ã®éã§ã5æã«ã¯äžéšæ¥çš®è ã®18æ³ãã39æ³ã®æ»äº¡çã¯ãæªæ¥çš®ã®18æ³ãã39æ³ã®æ»äº¡çãã202%ãé«ãã£ãã®ã§ããã
åå ±åæžã§ã¯ãè±åœæ¿åºã¯é ãããšããŠããããåã©ãã®æ»äº¡çãæããã«ããŠããã
以äžã®å³ã¯ãONSãæäŸããæ°å€ã«ããã2021幎1æ1æ¥ãã2022幎5æ31æ¥ãŸã§ã®æéã«ããããã€ã³ã°ã©ã³ãã®10æ³ãã14æ³ã®åã©ãã®10äžäººå¹Žãããã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡çã§ãã--ã

Covid-19ã®æ»äº¡çã«ã€ããŠãONSã¯10æ³ãã14æ³ã®ã¯ã¯ãã³æªæ¥çš®å ã®æ»äº¡çã¯0.31ã§ããããšãæããã«ããŠããããããã1åæ¥çš®ã®åã©ããã¡ã®æ»äº¡çã¯10äžäººå¹Žããã3.24人ã3åæ¥çš®ã®åã©ããã¡ã®æ»äº¡çã¯10äžäººå¹Žããã41.29人ãšè¡æçãªæ°åã«ãªã£ãŠããã
æ®å¿µãªãããCovid-19以å€ã®æ»äº¡çã«ã€ããŠã¯ãã»ãšãã©æ¹åãèŠãããªãã
å šæ»å æ»äº¡çã¯ãã¯ã¯ãã³æªæ¥çš®å ã§10äžäººå¹Žåœãã6.39人ãäžéšæ¥çš®å ã§6.48人ãšãããã«äžåã£ãŠããã
ãããããã®æ»äº¡çã¯æ³šå°ãæã€ãã³ã«ã©ãã©ãæªããªã£ãŠãããå šæ»å æ»äº¡çã¯ã2åæ¥çš®ããåã©ãã§97.28ã3åæ¥çš®ããåã©ãã§ã¯10äžäººå¹Žåœãã289.02ãšããè¡æçãªæ°åã«ãªã£ãŠããã
ã€ãŸããè±åœæ¿åºã®å ¬åŒããŒã¿ã«ãããšã2皮混åã¯ã¯ãã³ãæ¥çš®ããåã©ããã¡ã¯ãæªæ¥çš®ã®åã©ããã¡ã«æ¯ã¹ãŠ1422ïŒ /15.22åãããããåå ã§æ»äº¡ãã確çãé«ããšããããšã«ãªããŸããäžæ¹ã3皮混åã¯ã¯ãã³ãæ¥çš®ããåã©ããã¡ã¯ãæªæ¥çš®ã®åã©ããã¡ã«æ¯ã¹ãŠ4423% / 45.23åãäœããã®åå ã§æ»äº¡ããå¯èœæ§ãé«ããšããããšã§ãã
ãã®æ°åã¯ãOffice for National statisticsã«ãããã®ã§ãå¹Žéœ¢æšæºåããã人å£10äžäººãããã®æ°åã§ãããããã£ãŠããã®æ°åã¯ãã³ããã19泚å°ãäººã®æ»äº¡ãªã¹ã¯ãé«ãããšããæ±ºå®çãªèšŒæ ã§ãããã€ãŸããã³ããã19泚å°ã¯ããããŸã§ãããããŠãããããã人ã ãæ®ºãç¶ãããšããããšã ã
ãã®ãããCDCã®ç§å¯ã¬ããŒãããã³ããã»ã¯ã¯ãã³ã®å±éåŸã«50äžäººã®ã¢ã¡ãªã«ã®åäŸãšè¥å¹Žæäººãæ»äº¡ããããšã確èªããããšã¯ãé©ãããšã§ã¯ãããŸããã
